In aging mouse kidneys, senescent tubular cells cluster with macrophages in anatomically discrete cortical zones — termed senescence-associated inflammatory niches — whose inflammatory intensity tracks p16Ink4a burden more closely than chronological age. Spatial transcriptomics revealed co-enrichment of SASP, macrophage activation, and failed-repair tubular programs within these cortex-restricted neighborhoods. Both genetic and pharmacological senolytic strategies reduced senescent cell load and overall immune infiltration, yet macrophages persisted near residual senescent tubular structures, suggesting incomplete resolution of local immune-senescent crosstalk.
This work matters for several reasons. First, it reframes renal inflammaging from a diffuse process into one organized around discrete microenvironmental niches — a conceptual shift with real therapeutic implications. Senolytics like navitoclax and dasatinib/quercetin have shown promise in preclinical models, but this study's persistence finding implies that eliminating senescent cells alone may be insufficient; the macrophage niche may self-sustain or be fed by residual senescent structures. The p16Ink4a-versus-chronological-age dissociation is particularly striking: biological age, not calendar age, drives niche intensity, reinforcing calls to use molecular biomarkers rather than birth year in clinical trial stratification. Limitations are meaningful — this is entirely a murine study, and spatial transcriptomics in aged tissue carries dropout artifacts. Translation to human kidneys, where fibrotic and vascular complexity differs substantially, remains unconfirmed. Still, this is a methodologically rigorous, spatially resolved advance that upgrades our mechanistic map of kidney aging and sets a clear target: disrupting the macrophage-senescent cell feedback loop, not senescent cells alone.
